Moderna Cuts Full-Year Sales Guidance
This is a Moderna news story, published by Investor's Business Daily, that relates primarily to Moderna news.
Moderna news
For more Moderna news, you can click here:
more Moderna newsModerna news
For more Moderna news, you can click here:
more Moderna newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Moderna stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest competitive Covid market news, Covid vaccine maker news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
ModernaInvestor's Business Daily
•Moderna cuts full-year sales outlook, shares tumble 12% in premarket trade
78% Informative
For the year , Moderna now expects $3 billion to $3.5 billion in sales, below its previous guidance for about $4 billion .
Moderna stock tumbled 12% in premarket trade.
The guidance comes as Moderna launches its second -ever product, a vaccine for respiratory syncytial virus.
VR Score
81
Informative language
84
Neutral language
46
Article tone
formal
Language
English
Language complexity
44
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
3
Affiliate links
no affiliate links